Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 7—July 2021
Research

Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK

Gayatri AmirthalingamComments to Author , Heather Whitaker, Tim Brooks, Kevin Brown, Katja Hoschler, Ezra Linley, Ray Borrow, Colin Brown, Nick Watkins, David J. Roberts, Danielle Solomon, Charlotte M. Gower, Olivier le Polain de Waroux, Nick J. Andrews, and Mary E. Ramsay
Author affiliations: Public Heath England, London, UK (G. Amirthalingam, H. Whitaker, K. Brown, K. Hoschler, C. Brown, D. Solomon, C.M. Gower, O. le Polain de Waroux, N.J. Andrews, M.E. Ramsay); Public Health England, Porton Down, UK (T. Brooks); Public Health England, Manchester, UK (R. Borrow); National Health Service Blood and Transplant, Cambridge, UK (N. Watkins); National Health Service Blood and Transplant, Oxford, UK (D.J. Roberts); Radcliffe Department of Medicine, University of Oxford, Oxford (D.J. Roberts)

Main Article

Figure 1

Percentage of reactive test results (unadjusted) for severe acute respiratory syndrome coronavirus 2 Ig in serum samples, by assay and epidemiologic week of sample collection (weeks 13, 15–16, and 18), London, UK, 2020. Error bars indicate 95% CIs. RBD, receptor-binding domain.

Figure 1. Percentage of reactive test results (unadjusted) for severe acute respiratory syndrome coronavirus 2 Ig in serum samples, by assay and epidemiologic week of sample collection (weeks 13, 15–16, and 18), London, UK, 2020. Error bars indicate 95% CIs. RBD, receptor-binding domain.

Main Article

Page created: April 19, 2021
Page updated: June 16, 2021
Page reviewed: June 16, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external